TrialJournal of viral hepatitis2019

Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.

Steven Flamm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.